CH5138303 is an orally active Hsp90 inhibitor with potent anti-tumor activity; it exhibits growth inhibitory effects against HCT116 colorectal cancer and NCI-N87 gastric cancer cell lines; it demonstrates high oral bioavailability and significant anti-tumor efficacy in human NCI-N87 gastric cancer xenograft models in mice.